Service area · Wholesale distribution of medicinal products
Last updated: 27 August 2026
GDP processes for returned medicines, saleable-stock decisions, batch recalls, mock recalls, quarantine and suspected falsified medicines.
Review recall readiness →GDP returns · medicine recall · falsification
GDP processes for returned medicines, saleable-stock decisions, batch recalls, mock recalls, quarantine and suspected falsified medicines.
Time-critical quality events need predefined decisions, traceable data and clear communication. We connect SOPs, ERP/WMS status and Responsible Person governance.
tiger.PHARMA Kompetenz
Returns remain quarantined until origin, timing, conditions, integrity and traceability have been assessed.
The plan defines roles, availability, data sources, customer messages and authority escalation.
Suspect stock is immediately segregated and blocked while the defined investigation and notification route is activated.
Recall capability relies on consistent product, batch, serial and movement data.
FAQ
Only when the defined GDP criteria are met, storage and transport remain demonstrably acceptable, the pack is intact and an authorised decision is documented.
A planned exercise testing whether affected batches, recipients and quantities can be identified completely within the target time and communication routes work.
The product is immediately segregated and blocked from distribution, with the Responsible Person and required external parties engaged through the approved escalation route.